Physician profile
Sheldon Regenbaum
NPI 1134126014
$7,400.58
in general payments reported to CMS, 2019-2025
22 companies · $136 in 2025
The $136 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $235 · 2021: $1,206 · 2022: $1,844 · 2023: $3,531 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,389 · Food and Beverage: $1,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,388.93 |
| Food and Beverage | $1,277.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $1,675.19 | 2021-2023 | Nalu Neurostimulation System |
| Medtronic, INC. | $1,384.05 | 2022-2023 | Intellis Adaptivestim, Tyrx |
| Boston Scientific Corporation | $1,226.54 | 2019-2022 | |
| Spinal Simplicity, LLC | $1,161.32 | 2023 | Ha Minuteman G3-R |
| Abbott Laboratories | $609.52 | 2019-2023 | Proclaim, Prodigy |
| Vertos Medical, INC. | $333.48 | 2022-2023 | Mild Device Kit |
| Nevro Corp. | $315.94 | 2019-2023 | Senza |
| Allergan, INC. | $166.97 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $85.71 | 2019-2023 | Xtampza |
| Biodelivery Sciences International, INC. | $85.42 | 2019-2020 | |
| Globus Medical, INC. | $70.28 | 2025 | Senza |
| Relievant Medsystems, INC. | $51.97 | 2023 | Intracept |
| Biotronik Nro, INC. | $51.74 | 2025 | Prospera |
| Sentynl Therapeutics, INC. | $28.42 | 2019 | |
| Pfizer INC. | $27.33 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $22.76 | 2022 | |
| Valinor Pharma, LLC | $22.57 | 2023 | Movantik |
| Daiichi Sankyo INC. | $19.83 | 2019 | |
| Stimwave Technologies Incorporated | $19.40 | 2022 | |
| Vertiflex, INC. | $15.09 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $13.65 | 2025 | Riteclip |
| Astrazeneca Pharmaceuticals LP | $13.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Regenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.